Warrak Elias L, Haddam Majd S, Dandan Walid N, Warrak John E, Sammouh Fady K
Department of Ophthalmology and Visual Sciences, University of Balamand, Advanced Eye Care Hospital, Lebanon.
University of Balamand, Faculty of Medicine and Health Sciences, Lebanon.
Case Rep Ophthalmol Med. 2022 Jun 16;2022:1853248. doi: 10.1155/2022/1853248. eCollection 2022.
We report a case of a 54-year-old female patient who underwent PAC-IOL implantation 18 years prior to presentation. The patient had a best corrected visual acuity (BCVA) 20/20 in the right eye (OD) postoperatively with normal eye exam on routine follow-up since then. The patient presented for acute onset decreased visual acuity in the right eye. BCVA was 20/60, and exam showed blunted macular reflex with no evidence of inflammation. Optical coherence tomography (OCT) showed CME. She was started on topical treatment (ketorolac 0.5%) OD four times daily. Three weeks later, the patient had a BCVA of 20/20 OD with a normal macular reflex and an OCT showing the resolution of the CME. To our knowledge, this is the first reported case of a CME 18 years post PAC-IOL implantation. The possible cause of this incidence could be related to subclinical intraocular inflammation. Ophthalmologists should be aware of the possibility of such a latent CME post-PAC-IOL implantation.
我们报告一例54岁女性患者,该患者在就诊前18年接受了后房型人工晶状体(PAC-IOL)植入术。术后右眼(OD)最佳矫正视力(BCVA)为20/20,自那时起常规随访时眼部检查正常。该患者因右眼视力急性下降就诊。BCVA为20/60,检查显示黄斑反射迟钝,无炎症迹象。光学相干断层扫描(OCT)显示存在黄斑囊样水肿(CME)。开始对右眼每日4次局部使用0.5%酮咯酸治疗。三周后,患者右眼BCVA为20/20,黄斑反射正常,OCT显示CME消退。据我们所知,这是首例报道的PAC-IOL植入术后18年发生CME的病例。这种情况可能的原因可能与亚临床眼内炎症有关。眼科医生应意识到PAC-IOL植入术后发生这种潜伏性CME的可能性。